Incysus Therapeutics to Participate in Panel at the 2018 Life Sciences Summit
Panel Title: “Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies” NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell …